CPT1A and metabolic dysfunction-associated steatotic liver disease: In NAFLD mice, decreased CPT1 expression leads to the decreased transport of acyl-coenzyme A to mitochondria, thereby resulting in FA and acyl-coenzyme A deposition in the cytoplasm without entry into the mitochondria in the liver [10].